FIELD: medicine, pharmacology.
SUBSTANCE: composition of film coating is intended for coating pharmaceutical compositions with modified release, and contains dispertion, which includes acrylic polymer (a), vinylacetate polymer (b), and water-containing fluid (c). The film coating is used for modified release from pharmaceutical compositions such as tablets, pills, etc.
EFFECT: film coating is not sticky and has high mechanical strength.
35 cl, 4 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COATED COMPOUND CONTAINING PHARMACEUTICAL AGENT | 2004 |
|
RU2372893C2 |
| COMPOSITIONS WITH MODIFIED RELEASE, CONTAINING COMPLEXES MEDICATION-ION-EXCHANGING RESIN | 2007 |
|
RU2435569C2 |
| FORMULATIONS OF NON-OPIOID AND LIMITED OPIOID ANALGESICS | 2007 |
|
RU2477995C2 |
| GASTRAL-RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL COMPOSITION WITH SUSTAINABILITY TO THE ETHANOL IMPACT | 2012 |
|
RU2649806C2 |
| PHARMACEUTICAL FORMULATION WITH CONTROLLED-RELEASE ACTIVE SUBSTANCE | 2004 |
|
RU2447884C2 |
| MEDICINAL RETARD-FORMULATION CONTAINING TRAMADOL SACCHARINATE | 2000 |
|
RU2292877C2 |
| COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTICAL DOSAGE FORMS | 2011 |
|
RU2606588C2 |
| EXTENDED-RELEASE FORMULATION FOR REDUCING THE FREQUENCY OF URINATION AND METHOD OF USE THEREOF | 2012 |
|
RU2603471C2 |
| PHARMACEUTICAL COMPOSITIONS WITH DEFERRED RELEASE CONTAINING VALPROIC ACID AND THEIR USE | 2017 |
|
RU2760304C2 |
| COMBINED CONTROLLED-RELEASE PHARMACEUTICAL AGENT CONTAINING DIHYDROPYRIDINE CALCIUM CANAL BLOCKERS AND HMG-CoA-REDUCTASE INHIBITORS | 2007 |
|
RU2450804C2 |
